In-vitro Bone Marrow Niche Platform and Pre-clinical Screening Kit

Posted on October 3, 2015

An artificial bone marrow microenvironment (ABME) platform for enhancing and regulating in-vitro as well as in vivo formation of stem cells has been created by scientist at NCCS, Pune. This technology can be incorporated into high throughput and micro-fluidic devices for drug screening and in-vitro toxicology testing. Continue reading →

Posted in Biopharma, Cell Therapy, In-vitro Platform, Regenerative medicine, Stem Cells, Umbilical Cord Blood Banking

Tagged

Technology Readiness Levels (TRL)

Posted on September 20, 2015
TRL A: Technology concept formulated
TRL B: Proof-of-concept demonstrated in lab scale

  • TRL B1 : In-vitro efficacy/ results demonstrated
  • TRL B2 : In-vivo efficacy/ results demonstrated; TRL B1 + In-vivo efficacy/ results demonstrated
  • TRL B3 : TRLB2 + Safety & Toxicology demonstrated; TRL B1 + Safety & Toxicology demonstrated
TRL C: Prototype developed and tested; technology demonstrated at pilot scale (or a scale close to eventual use)
TRL D: Product or service offering tested in real/ field trials; Trial use by test customers; Clinical Trials completed
TRL E: Commercial production/ service offerings in place
TRL F: Proven technology with respect to established market

Posted in Resources

An Overview of NCCS Capabilities

Posted on September 19, 2015
Capability Area NCCS Scientists/ Consultants
Cancer Biology Dr. Sharmila Bapat, Dr. Padma Shastry, Dr. Anjali Shiras, Dr. Mohan Wani, Dr. Gopal Kundu, Dr. Samit Chattopadhyay, Dr. Manoj Kumar Bhat, Dr. Sandhya Sitaswad, Dr. Girdhari Lal, Dr. Srikanth Rapole, Dr. Manas Santra
Cell Biology Dr. Shekhar Mande, Dr. Mohan Wani, Dr. Debashis Mitra, Dr. Prakash Deshpande, Dr. Jomon Joseph,  Dr. Bhaskar Saha, Dr. Milind Patole, Dr. Arvind Sahu, Dr. M. V. Krishnasastry, Dr. Vasudevan Seshadri, Dr. Radha Chauhan, Dr. Janesh Kumar, Dr. Girdhari Lal, Dr. Shailza Singh, Dr. Deepa Subramanyam
Genetics Dr. Sharmila Bapat, Dr. Anjali Shiras, Dr. Samit Chattopadhyay, Dr. Jomon Joseph, Dr. Vasudevan Seshadri, Dr. Manas Santra, Dr. Vidisha Tripathi
Immunology  Dr. Mohan Wani, Dr. Bhaskar Saha, Dr. Arvind Sahu, Dr. Girdhari Lal, Dr. Shailza Singh
Metabolic Diseases Dr. Manoj Kumar Bhat, Dr. Sandhya Sitaswad
Microbial Biology Dr. Milind Patole, Dr. Yogesh Shouche, Dr. Shailza Singh
Neuroscience Dr. Amitabha Majumdar, Dr. Janesh Kumar
Stem Cells Dr. Vaijayanti Kale, Dr. Lalita Limaye, Dr. Anjali Shiras, Dr. Nibedita Lenka, Dr. Deepa Subramanyam

Posted in Biopharma, Cancer Biology, Cell Biology, Cell Therapy, Diagnostics, Genetics, Immunology, In-vitro Platform, Medical Device, Metabolic Diseases, Microbial Biology, Neuroscience, Nutraceutical, Regenerative medicine, Stem Cells, Umbilical Cord Blood Banking

Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Venture Center signs MoU with NCCS

Posted on September 18, 2015

Venture Center, a not-for-profit technology business incubator located in Pune, has signed a memorandum of understanding (MoU) with the National Centre for Cell Science (NCCS), Pune on 18th September 2015, for scanning and showcasing capabilities and technology developed by NCCS scientists for interested partners in Industry and Start-ups.

This engagement was brought about to assist NCCS in advancing its research and development activities towards commercialization objectives and promoting entrepreneurial activities. During the period of this engagement, Venture Center will be communicating with scientists at NCCS and showcasing their technology and capabilities for potential collaborators from the industry. This information will be periodically updated on the website: http://www.venturecenter.co.in/nccs/. Terms of MoU are available for review for NCCS scientists.

DSC02833

Posted in News